Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes [Emerging Investigators]

Conclusions: CF-LVAD utilization may lower waitlist mortality at the expense of lower likelihood of HT. Decision to use CF-LVAD and timing of transition should be individualized based on patient-, center-, and region-level risk factors to achieve optimal outcomes.

http://circheartfailure.ahajournals.org/cgi/content/short/11/4/e004586?rss=1

Source: Circulation: Heart Failure - April 17, 2018 Category: Cardiology Authors: Truby, L. K., Garan, A. R., Givens, R. C., Takeda, K., Takayama, H., Trinh, P. N., Yuzefpolskaya, M., Farr, M. A., Naka, Y., Colombo, P. C., Topkara, V. K. Tags: Heart Failure, Transplantation Emerging Investigators Source Type: research